These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33765158)

  • 21. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.
    Carlier J; Diao X; Sempio C; Huestis MA
    AAPS J; 2017 Mar; 19(2):568-577. PubMed ID: 28070717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
    Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
    Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
    Lam RPK; Tang MHY; Leung SC; Chong YK; Tsui MSH; Mak TWL
    Clin Toxicol (Phila); 2017 Aug; 55(7):662-667. PubMed ID: 28393558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
    Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
    Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
    Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
    Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
    Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing for SGT-151 (CUMYL-PEGACLONE) and its Metabolites in Blood and Urine after Surreptitious Administration.
    Aknouche F; Ameline A; Richeval C; Schapira AJ; Coulon A; Maruejouls C; Gaulier JM; Kintz P
    J Anal Toxicol; 2020 Jan; 44(1):75-80. PubMed ID: 30877795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
    Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Flying high?'-Jump from a height in a 'Spice' high?: A case report on the synthetic cannabinoid 5F-MDMB-P7AICA.
    Walle N; Doerr AA; Schmidt PH; Schaefer N
    Drug Test Anal; 2023 Mar; 15(3):368-373. PubMed ID: 36415074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The First Reported Case of a Synthetic Cannabinoid Ethyl Ester Detected in a Postmortem Blood Toxicological Analysis.
    Apirakkan O; Hudson S; Couchman L; Cowan D; Morley S; Abbate V
    J Anal Toxicol; 2021 Jan; 44(9):1052-1056. PubMed ID: 32369163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
    Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
    Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADB-HEXINACA-a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market.
    Giorgetti A; Zschiesche A; Groth O; Haschimi B; Scheu M; Pelletti G; Fais P; Musshoff F; Auwärter V
    Drug Test Anal; 2024 Feb; ():. PubMed ID: 38350637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new designer drug 5F-ADB activates midbrain dopaminergic neurons but not serotonergic neurons.
    Asaoka N; Kawai H; Nishitani N; Kinoshita H; Shibui N; Nagayasu K; Shirakawa H; Kaneko S
    J Toxicol Sci; 2016; 41(6):813-816. PubMed ID: 27853110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review.
    Navarro-Tapia E; Codina J; Villanueva-Blasco VJ; García-Algar Ó; Andreu-Fernández V
    Biology (Basel); 2022 May; 11(5):. PubMed ID: 35625524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA.
    Schwartz MD; Trecki J; Edison LA; Steck AR; Arnold JK; Gerona RR
    J Emerg Med; 2015 May; 48(5):573-80. PubMed ID: 25726258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.
    Gaunitz F; Kieliba T; Thevis M; Mercer-Chalmers-Bender K
    Drug Test Anal; 2020 Jan; 12(1):27-40. PubMed ID: 31412168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700.
    Richeval C; Gaulier JM; Romeuf L; Allorge D; Gaillard Y
    Int J Legal Med; 2019 Jan; 133(1):133-142. PubMed ID: 30443678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor vehicle collisions caused by the 'super-strength' synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014.
    Kaneko S
    Forensic Toxicol; 2017; 35(2):244-251. PubMed ID: 28706566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
    Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
    Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.